CardioNXT Obtains $1,500,000 New Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    Undisclosed Westminster, CO 80021 USA
  • Company Description
    We are fortunate to have found a partner in Solas BioVentures that truly appreciates our vision and mission of helping treat patients with cardiac arrhythmias such as AFib in a manner that is affordable for the entire world.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor

Trending on Xconomy